Market Research Industry Reports

Dermatomyositis - Pipeline Review, H1 2018

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Dermatomyositis - Pipeline Review, H1 2018

Summary

Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline Review, H1 2018, provides an overview of the Ankylosing Spondylitis (Bekhterevs Disease) (Musculoskeletal Disorders) pipeline landscape.

Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spines bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture.

Report Highlights

Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Bekhterevs Disease) (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Ankylosing Spondylitis (Bekhterevs Disease) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterevs Disease) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 6, 9, 6, 5, 13, 8 and 2 respectively.

Ankylosing Spondylitis (Bekhterevs Disease) (Musculoskeletal Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Ankylosing Spondylitis (Bekhterevs Disease) (Musculoskeletal Disorders).
- The pipeline guide reviews pipeline therapeutics for Ankylosing Spondylitis (Bekhterevs Disease) (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Ankylosing Spondylitis (Bekhterevs Disease) (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Ankylosing Spondylitis (Bekhterevs Disease) (Musculoskeletal Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Ankylosing Spondylitis (Bekhterevs Disease) (Musculoskeletal Disorders)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Ankylosing Spondylitis (Bekhterevs Disease) (Musculoskeletal Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Ankylosing Spondylitis (Bekhterevs Disease) (Musculoskeletal Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.


Introduction 5
Ankylosing Spondylitis (Bekhterevs Disease) - Overview 6
Ankylosing Spondylitis (Bekhterevs Disease) - Therapeutics Development 7
Ankylosing Spondylitis (Bekhterevs Disease) - Therapeutics Assessment 14
Ankylosing Spondylitis (Bekhterevs Disease) - Companies Involved in Therapeutics Development 22
Ankylosing Spondylitis (Bekhterevs Disease) - Drug Profiles 36
Ankylosing Spondylitis (Bekhterevs Disease) - Dormant Projects 182
Ankylosing Spondylitis (Bekhterevs Disease) - Discontinued Products 184
Ankylosing Spondylitis (Bekhterevs Disease) - Product Development Milestones 185
Appendix 195

List Of Tables

List of Tables
Number of Products under Development for Ankylosing Spondylitis (Bekhterevs Disease), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Products under Development by Companies, H1 2018
Products under Development by Companies, H1 2018 (Contd..1), H1 2018
Products under Development by Companies, H1 2018 (Contd..2), H1 2018
Number of Products by Stage and Target, H1 2018
Number of Products by Stage and Mechanism of Action, H1 2018
Number of Products by Stage and Route of Administration, H1 2018
Number of Products by Stage and Molecule Type, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by AbbVie Inc, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Adello Biologics LLC, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Alteogen Inc, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Amgen Inc, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Biocad, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Biocon Ltd, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Bionovis SA, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Celgene Corp, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Coherus BioSciences Inc, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Eli Lilly and Co, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Fresenius SE & Co KGaA, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Galapagos NV, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Genor BioPharma Co Ltd, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Immunwork Inc, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Innovent Biologics Inc, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Izana Bioscience Ltd, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Mycenax Biotech Inc, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Nichi-Iko Pharmaceutical Co Ltd, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Novartis AG, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Nuevolution AB, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Oncobiologics Inc, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Pfizer Inc, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Protalix BioTherapeutics Inc, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Reliance Life Sciences Pvt Ltd, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Sandoz International GmbH, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Shanghai Pharmaceutical Co Ltd, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Sun Pharma Advanced Research Company Ltd, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by UCB SA, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline by Xbrane Biopharma AB, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Dormant Projects, H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Dormant Projects, H1 2018 (Contd..1), H1 2018
Ankylosing Spondylitis (Bekhterevs Disease) - Discontinued Products, H1 2018

List Of Figures

List of Figures
Number of Products under Development for Ankylosing Spondylitis (Bekhterevs Disease), H1 2018
Number of Products under Development by Companies, H1 2018
Number of Products by Top 10 Targets, H1 2018
Number of Products by Stage and Top 10 Targets, H1 2018
Number of Products by Top 10 Mechanism of Actions, H1 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2018
Number of Products by Routes of Administration, H1 2018
Number of Products by Stage and Routes of Administration, H1 2018
Number of Products by Molecule Types, H1 2018
Number of Products by Stage and Top 10 Molecule Types, H1 2018

Dermatomyositis - Pipeline Review, H1 2018

Dermatomyositis - Pipeline Review, H1 2018Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Ankylosing Spondylitis (Bekhterevs Disease) - Pipeline Review, H1 2018, provides an overview of the Ankylosing

USD 2000View Report

Dermatomyositis - Pipeline Review, H2 2017

Dermatomyositis - Pipeline Review, H2 2017Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Dermatomyositis - Pipeline Review, H2 2017, provides an overview of the Dermatomyositis (Musculoskeletal Disorders) pipeline

USD 2000View Report

Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Pipeline Review, H1 2018

Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Pipeline Review, H1 2018Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or

USD 3500View Report

cAMP and cAMP Inhibited cGMP 3,5 Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H1 2018

cAMP and cAMP Inhibited cGMP 3,5 Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H1 2018cAMP and cAMP Inhibited

USD 3500View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 2000
  • Site Licence    USD 4000
  • Enterprise Wide Licence    USD 6000
$ 2000

Reports Details

Published Date : May 2018
No. of Pages :201
Country :Global
Category :Pharmaceuticals and Healthcare
Publisher :Global Markets Direct
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube